OPNT has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
OPNT has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Short Percentage of Float is the percentage of shares shorted compared to the float.
Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.
For the Biotechnology subindustry, Opiant Pharmaceuticals's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, Opiant Pharmaceuticals's Short Percentage of Float distribution charts can be found below:
* The bar in red indicates where Opiant Pharmaceuticals's Short Percentage of Float falls into.
David D O'toole | officer: Chief Financial Officer | 1640 MARENGO STREET, LOS ANGELES CA 90033 |
Ellison Mark Jason Heath | other: UK Managing Director | C/O OPIANT PHARMACEUTICALS, INC., 201 SANTA MONICA BLVD., SUITE 500, SANTA MONICA CA 90401 |
Roger Crystal | director, 10 percent owner, officer: Chief Executive Officer | 445 PARK AVE, 10TH FL., NEW YORK NY 10022 |
Phil Skolnick | officer: Chief Scientific Officer | C/O DOV PHARMACEUTICAL, INC., 433 HACKENSACK AVENUE, HACKENSACK NJ 07601 |
Brian Gorman | other: General Counsel | 233 WILSHIRE BLVD, SUITE 280, SANTA MONICA CA 90401 |
Matthew R. Ruth | officer: Chief Commercial Officer | 233 WILSHIRE BLVD., SUITE 280, SANTA MONICA CA 90401 |
Michael Sinclair | director, 10 percent owner, officer: Executive Chairman | 86 GLOUCESTER PLACE, LONDON XX W1U6HP |
Craig A Collard | director | C/O CORNERSTONE THERAPEUTICS INC., 1255 CRESCENT GREEN DRIVE, SUITE 250, CARY NC 27518 |
Ann L. Macdougall | director | C/O OPIANT PHARMACEUTICALS, INC., 401 WILSHIRE BOULEVARD, 12TH FLOOR, SANTA MONICA CA 90401 |
Thomas T. Thomas | director | C/O OPIANT PHARMACEUTICALS, INC., 401 WILSHIRE BOULEVARD, 12TH FLOOR, SANTA MONICA CA 90401 |
Masuoka K. Lorianne | director | C/O NEKTAR THERAPEUTICS, 201 INDUSTRIAL ROAD, SAN CARLOS CA 94070 |
Gabrielle Alison Silver | director | C/O OPIANT PHARMACEUTICALS, INC., 401 WILSHIRE BOULEVARD, 12TH FLOOR, SANTA MONICA CA 90401 |
Rahsaan Thompson | other: General Counsel | 233 WILSHIRE BOULEVARD, SUITE 280, SANTA MONICA CA 90401 |
Aziz Mottiwala | officer: Chief Commercial Officer | 233 WILSHIRE BOULEVARD, SUITE 280, SANTA MONICA CA 90401 |
Richard J Daly | director | 355 ALHAMBRA CIRCLE, SUITE 1500, CORAL GABLES FL 33134 |
From GuruFocus
By Value_Insider Value_Insider • 11-22-2022
By Business Wire Business Wire • 11-14-2022
By Stock market mentor Stock market mentor • 02-07-2023
By GuruFocusNews GuruFocusNews • 07-09-2022
By PRNewswire PRNewswire • 11-18-2022
By PRNewswire PRNewswire • 11-14-2022
By PRNewswire PRNewswire • 11-14-2022
By Value_Insider Value_Insider • 11-14-2022
By Value_Insider Value_Insider • 12-08-2022
By Value_Insider Value_Insider • 11-15-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.